C1q nephropathy: Features at presentation and outcome

Pediatric Nephrology

Volumn 20, Issue 6, 2005, Pages 744-749

  Lau, Keith K ^a   Gaber, Lillian W ^b   Delos Santos, Noel M ^a,b   Wyatt, Robert J ^a,b  

^a LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

C1q nephropathy; End stage renal disease; Glomerulonephritis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ADOLESCENT; AGE; ARTICLE; BLOOD PRESSURE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT COMPONENT C1Q NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMATURIA; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COMPLEMENT C1Q; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROTEINURIA; TISSUE SURVIVAL;

EID: 18644369327     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1810-8     Document Type: Article

References (21)

1. Jennette JC, Hipp CG C1q Nephropathy (1985) A distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 103-110:1985
2. Jennette JC, Falk RJ (2004) C1q nephropathy. In Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott-Williams & Wilkins, Philadelphia, pp 730-733
3. Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: A pediatric clinicopathologic study. Am J Kidney Dis 18:459-465
4. Markowitz GS, Schwimmer JA, Stokes BM, Nasr S, Siegle RL, Valeri AM, D'Agati VD (2003) C1q nephropathy: A variant of focal segmental glomerulosclerosis. Kidney Int 64:1232-1240
5. Sharman A, Furness P, Feehally J (2004) Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19:1420-1426
6. Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephritic syndrome: Minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966-970
7. Srivastava T, Chadha V, Taboada EM, Alon U (2000) C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol 14:976-979
8. Ekim M, Ikinciogullari A, Berberoglu M, Tulunay O, Sencer H, Ozkaya N, Reisli I, Tumer N (2002) C1q nephropathy: A case with severe atopic dermatitis. Pediatr Nephrol 17:547-549
9. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents. Pediatrics 98:649-658 8885941
10. Schwartz GL, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263 1:CAS:528:DyaE28XlsFKisr4%3D
11. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH (1984) IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4:192-200
12. Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ (2004) Pediatric IgA nephropathy: Clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol 62:167-172
13. Jennette JC, Hippe CG (1985) Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83:415-420
14. Jones E, Magil A (1982) Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Am J Clin Pathol 78:29-34
15. Enriquez JL, Rajaraman S, Kalia A, Brouhard BH, Travis LB (1988) Isolated antibody-negative lupus nephropathy in young children. Child Nephrol Urol 9:340-346
16. Wyatt RJ (1993) The complement system in IgA nephropathy and Henoch-Schönlein purpura: Functional and genetic aspects. Contrib Nephrol 104:82-91
17. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R (1984) Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 21:335-340
18. Kusunoki Y, Itami N, Tochimura H, Takekoshi Y, Nagasawa R (1987) Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron 51:17-19
19. Wyatt RJ, Kanayama Y, Julian BA, Negoro N, Sugimoto S, Hudson EC, Curd JG (1987) Complement activation in IgA nephropathy. Kidney Int 31:1019-1023
20. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Defective galactosylation and clearance of IgA1 as a possible etiopathologic factor in IgA nephropathy. Contrib Nephrol 104:172-182
21. Yoshikawa N, Iijima K, Shimomura M, Nakamura H, Ito H (1994) IgG-associated primary glomerulonephritis in children. Clin Nephrol 42:281-287